CYT 004 MelQbG10
Alternative Names: CYT004-MelQbG10; Melan-A VLP vaccine - Cytos; Melanoma virus-like particle vaccine - CytosLatest Information Update: 31 Aug 2011
At a glance
- Originator Cytos Biotechnology
- Class Cancer vaccines; Virus-like particle vaccines
- Mechanism of Action T lymphocyte stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Malignant melanoma
Most Recent Events
- 01 Jul 2010 Cytos Biotechnology completes a phase II trial in Malignant melanoma in Switzerland
- 24 Feb 2009 Phase II development is ongoing in Switzerland
- 22 Nov 2007 Interim immunogenicity, adverse event and efficacy data from three phase IIa trials in malignant melanoma released by Cytos Biotechnology